![]()
|
|
||||||||
From the
1 From the Division of Biology, Kansas State University, Manhattan, Kansas 66502
In Escherichia coli, the nicotinamide moiety of pyridine nucleotides may be derived from de novo synthesis of the pyridine ring or through the uptake of either nicotinic acid or nicotinamide. De novo synthesis is the least preferred pathway; it is suppressed if an exogenous source is available. Nicotinamide is kinetically preferred over nicotinic acid; the data are consistent with the hypothesis that nicotinamide can pass through the bacterial membrane much faster than can the charged nicotinic acid, and once inside the cell, the amide is efficiently converted to the acid. Thus even at low concentrations nicotinamide is instantly taken up by cells, but at concentrations of less than 8 x 10-6 m nicotinic acid in the medium, the rate of entry of the nicotinic acid into the cell appears to be the rate-limiting step in the synthesis of pyridine nucleotide from exogenous niacin. Under conditions where sufficient exogenous niacin or nicotinamide is present so that entry into the cell is not limiting, the rate of pyridine nucleotide biosynthesis is apparently regulated by the rate of conversion of nicotinic acid
Pyridine Nucleotide Metabolism in Escherichia coli
III. BIOSYNTHESIS FROM ALTERNATIVE PRECURSORS IN VIVO
2 From the Department of Biology, University of Utah, Salt Lake City, Utah 84112, and the Department of Biochemistry, University of the Philippines, Manila, Philippines
nicotinic acid mononucleotide, as suggested by Imsande and Pardee ((1962) J. Biol. Chem. 237, 1305). Since the rate of conversion of nicotinamide
nicotinic acid is not regulated, excess nicotinic acid that is formed from nicotinamide is continually excreted into the medium.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Zhang, A. Scorpio, H. Nikaido, and Z. Sun Role of Acid pH and Deficient Efflux of Pyrazinoic Acid in Unique Susceptibility of Mycobacterium tuberculosis to Pyrazinamide J. Bacteriol., April 1, 1999; 181(7): 2044 - 2049. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |